DexCom Inc (DXCM)
68.99
-0.71
(-1.02%)
USD |
NASDAQ |
Nov 05, 16:00
69.02
+0.03
(+0.04%)
After-Hours: 18:32
DexCom Market Cap: 26.95B for Nov. 5, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 04, 2024 | 27.22B |
| November 01, 2024 | 27.48B |
| October 31, 2024 | 27.53B |
| October 30, 2024 | 28.04B |
| October 29, 2024 | 28.22B |
| October 28, 2024 | 28.16B |
| October 25, 2024 | 28.69B |
| October 24, 2024 | 29.24B |
| October 23, 2024 | 28.31B |
| October 22, 2024 | 28.54B |
| October 21, 2024 | 28.36B |
| October 18, 2024 | 28.27B |
| October 17, 2024 | 27.17B |
| October 16, 2024 | 27.30B |
| October 15, 2024 | 26.21B |
| October 14, 2024 | 27.02B |
| October 11, 2024 | 27.03B |
| October 10, 2024 | 27.17B |
| October 09, 2024 | 27.19B |
| October 08, 2024 | 27.12B |
| October 07, 2024 | 26.80B |
| October 04, 2024 | 26.60B |
| October 03, 2024 | 25.65B |
| October 02, 2024 | 26.21B |
| October 01, 2024 | 25.78B |
| Date | Value |
|---|---|
| September 30, 2024 | 26.19B |
| September 27, 2024 | 26.96B |
| September 26, 2024 | 27.06B |
| September 25, 2024 | 26.74B |
| September 24, 2024 | 27.51B |
| September 23, 2024 | 27.93B |
| September 20, 2024 | 28.22B |
| September 19, 2024 | 28.82B |
| September 18, 2024 | 27.83B |
| September 17, 2024 | 27.63B |
| September 16, 2024 | 28.09B |
| September 13, 2024 | 27.85B |
| September 12, 2024 | 27.58B |
| September 11, 2024 | 27.44B |
| September 10, 2024 | 27.47B |
| September 09, 2024 | 27.93B |
| September 06, 2024 | 27.49B |
| September 05, 2024 | 27.67B |
| September 04, 2024 | 27.98B |
| September 03, 2024 | 29.00B |
| August 30, 2024 | 27.79B |
| August 29, 2024 | 27.90B |
| August 28, 2024 | 28.24B |
| August 27, 2024 | 28.95B |
| August 26, 2024 | 29.52B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
14.01B
Minimum
Nov 06 2019
63.12B
Maximum
Nov 17 2021
39.44B
Average
40.06B
Median
Nov 17 2023
Market Cap Benchmarks
| Orthofix Medical Inc | 676.08M |
| Abbott Laboratories | 204.16B |
| Bristol-Myers Squibb Co | 113.46B |
| Edwards Lifesciences Corp | 40.17B |
| Tandem Diabetes Care Inc | 2.169B |
Market Cap Related Metrics
| PE Ratio | 41.31 |
| PS Ratio | 7.244 |
| PEG Ratio | 0.4946 |
| Price to Book Value | 13.62 |
| Price to Free Cash Flow | 53.54 |
| Price | 68.99 |
| Earnings Yield | 2.42% |
| PEGY Ratio | 0.4946 |
| Operating PE Ratio | 45.61 |
| Normalized PE Ratio | 41.31 |